Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Ardelyx Inc. has 3 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 3 distinct examiners and 3 distinct art units, giving each active matter a separate examination and technical assignment.
SEAMAN, D MARGARET M is the busiest examiner, with 1 pending matter. Counsel can focus on application-specific claim and prior-art issues while maintaining separate tracking for the different art-unit assignments.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Double-patenting only | 1 (33%) |
| Double-patenting + other | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SEAMAN, D MARGARET M | 1 | 76.6% | +8.1% |
| SHIAO, REI TSANG | 1 | 79.9% | -33.5% |
| SONG, JIANFENG | 1 | 56.4% | +33.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18381799 | COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT | SONG, JIANFENG | — |
| Art Unit | Apps |
|---|---|
| 1625 | 1 |
| 1691 | 1 |
| 1613 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19070289 | COMPOUNDS USEFUL FOR TREATING GASTROINTESTINAL TRACT DISORDERS | SEAMAN, D MARGARET M | 1625 | DP | Non-Final OA | — | Pending | Mar 04, 2025 |
| 18662929 | NHE3-BINDING COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT | SHIAO, REI TSANG | 1691 | §112DP | Non-Final OA | — | Pending | May 13, 2024 |
| 18381799 | COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT | SONG, JIANFENG | 1613 | §103Other | Final Rejection | — | Pending | Oct 19, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialArdelyx Inc. has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
D Margaret M Seaman has the most, with 1 of Ardelyx Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
